Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 2 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate CancerRecruitingNCT07311694Phase 3
• A Study of SHR-1819 Injection in Adolescents With Severe Atopic DermatitisRecruitingNCT07309055Phase 3
• A Study of SHR-2173 in Participants With Systemic Lupus ErythematosusRecruitingNCT07299422Phase 2
• A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid TumorsRecruitingNCT07298772Phase 1/2
• HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid TumorsRecruitingNCT07296341Phase 1/2
• Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous NephropathyRecruitingNCT07289763Phase 2
• A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingNCT07286032Phase 3
• A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid TumorRecruitingNCT07275242Phase 1
• A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection FractionRecruitingNCT07269717Phase 2
• A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid TumorsRecruitingNCT07268040Phase 2
• A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental VitiligoRecruitingNCT07251595Phase 2
• A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung CancerRecruitingNCT07241767Phase 2
• A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate CancerRecruitingNCT07241416Phase 3
• Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell CarcinomRecruitingNCT07239596Phase 1/2
• Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic CancerRecruitingNCT07238283Phase 3
• HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic CancerRecruitingNCT07232875Phase 3
• A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT07232849Phase 2
• A Study of SHR-4610 Injection in Patients With Advanced Solid TumorsRecruitingNCT07231211Phase 1/2
• A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaRecruitingNCT07230730Phase 3
• A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood PressureNot yet recruitingNCT07230145Phase 1
• A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate CancerRecruitingNCT07230106Phase 2
• A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel DiseaseRecruitingNCT07229950Phase 2
• A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With DyslipidemiaRecruitingNCT07229937Phase 2
• A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus NephritisRecruitingNCT07229742Phase 2
• A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung CancerRecruitingNCT07229729Phase 2
• A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid TumorsRecruitingNCT07229638Phase 1/2
• A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)RecruitingNCT07229625Phase 3
• A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid TumorsRecruitingNCT07229612Phase 1/2
• A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid TumorsRecruitingNCT07229586Phase 1/2
• A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic DermatitisRecruitingNCT07211542Phase 2
• Phase I Study of SHR-2173 Injection in Patients With Primary Immune ThrombocytopeniaRecruitingNCT07206758Phase 1
• Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary FibrosisRecruitingNCT07192939Phase 2
• A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or AmplificationsRecruitingNCT07189949Phase 1
• A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal SurgeryRecruitingNCT07185594Phase 2/3
• Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer SubjectsRecruitingNCT07175220Phase 2
• Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT07170995Phase 3
• A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical CancerRecruitingNCT07168200Phase 3
• Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight SubjectsRecruitingNCT07150962Phase 1
• A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or AmplificationsRecruitingNCT07142980Phase 1
• A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid TumorRecruitingNCT07140393Phase 1/2
• A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid TumorsRecruitingNCT07136142Phase 1/2
• Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D MutationsRecruitingNCT07134998Phase 1
• Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial HypercholesterolemiaNot yet recruitingNCT07133815Phase 2
• Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal PolypsRecruitingNCT07132827Phase 3
• A Trial of SHR-7782 for Treatment of Advanced Malignant TumorsRecruitingNCT07123129Phase 1
• A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT07118527Phase 3
• A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast CancerRecruitingNCT07111832Phase 3
• A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ CancerRecruitingNCT07110571Phase 2
• Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction AdenocarcinomaRecruitingNCT07102901Phase 2
• A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque PsoriasisNot yet recruitingNCT07102888Phase 2
• A Trial of SHR-1905 in Subjects With Severe Uncontrolled AsthmaRecruitingNCT07098403Phase 3
• Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant TumorsRecruitingNCT07073534Phase 1/2
• A Trial of HRS-6213 in Healthy Subjects and Patients With Solid TumorsRecruitingNCT07070349Phase 1/2
• A Clinical Study of SHR-4506 Injection in Patients With Malignant TumorsRecruitingNCT07068932Phase 1
• Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal InsulinRecruitingNCT07060456Phase 3
• A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma CancerRecruitingNCT07059221Phase 1/2
• Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer PatientsNot yet recruitingNCT07056439Phase 1/2
• A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical CancerRecruitingNCT07051486Phase 2
• A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 DiabetesRecruitingNCT07032688Phase 1
• A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid TumorsRecruitingNCT07032077Phase 2
• A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid TumorsRecruitingNCT07028281Phase 2
• A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid TumorsRecruitingNCT07028268Phase 2
• A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast CancerRecruitingNCT07024173Phase 3
• A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic CardiomyopathyRecruitingNCT07021963Phase 2
• A Trial of HRS-5965 Capsule in Primary IgA NephropathyRecruitingNCT07014826Phase 3
• A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT07003321Phase 2
• A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) TherapyRecruitingNCT06994650Phase 3
• A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHLNot yet recruitingNCT06981988Phase 1/2
• A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast CancerRecruitingNCT06974929Phase 1/2
• A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and ObesityRecruitingNCT06974851Phase 3
• Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With AsthmaNot yet recruitingNCT06940700Phase 2
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 InjectionRecruitingNCT06934408Phase 1
• A Trial of HRS-6768 in Patients With Advanced Solid TumorsRecruitingNCT06925581Phase 1/2
• A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT06922357Phase 1/2
• To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II StudyNot yet recruitingNCT06918743Phase 2
• A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant TumourRecruitingNCT06915142Phase 2
• A Trial of SHR-3792 Injection in Patients With Advanced Solid TumorsRecruitingNCT06907628Phase 1
• A Study of SHR-9803 for Injection in Patients With Advanced Solid TumorsNot yet recruitingNCT06906731Phase 1/2
• A Single Ascending Dose of HRS-4029 in Healthy SubjectsNot yet recruitingNCT06905314Phase 1
• A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid TumorsRecruitingNCT06895928Phase 2
• Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)RecruitingNCT06879145Phase 2/3
• A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial SpondyloarthritisRecruitingNCT06860750Phase 3
• SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical CancerRecruitingNCT06859775Phase 1/2
• A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLCRecruitingNCT06844474Phase 2
• A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian CancerRecruitingNCT06840002Phase 1/2
• The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06833307Phase 3
• A Study of SHR-A1811 in Subjects With Ovarian CancerRecruitingNCT06828354Phase 3
• Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and ObesityRecruitingNCT06820099Phase 2
• A Study of SHR-4394 Injection in Subjects With Prostate CancerRecruitingNCT06783829Phase 1
• Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque PsoriasisNot yet recruitingNCT06779097Phase 4
• A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract CancerRecruitingNCT06778031Phase 2
• Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis BronchiectasisRecruitingNCT06775340Phase 2
• A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid TumorsRecruitingNCT06770569Phase 1
• A Study of SHR-4375 in Subjects With Solid TumorsRecruitingNCT06764628Phase 1/2
• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLCRecruitingNCT06754930Phase 1/2
• A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial CarcinomaRecruitingNCT06738251Phase 3
• A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid TumorsRecruitingNCT06737731Phase 1/2
• Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid TumorsRecruitingNCT06735144Phase 1/2
• The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric InfarctionRecruitingNCT06732648Phase 2/3
• A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord ConditionsNot yet recruitingNCT06731829Phase 2

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas